Archive: December 17 2020
Find relevant news articles from other European projects, below:
Browse our carefully curated library of the latest news and developments in all areas of immunotherapy here:
UCART22 for R/R B-cell ALL
Nitin Jain, MD, University of Texas MD Anderson Cancer Center, Houston, TX, presents the preliminary results of Balli-01 (NCT04150497), a Phase I study trialling the chimeric antigen receptor (CAR) T-cell therapy, UCART22, in adult patients with relapsed/refractory (R/R) B-cell acute lymphoblastic leukemia (ALL).
Future directions for multiple myeloma treatment
Thomas Martin, MD, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, gives an overview of the evolving treatment paradigm for multiple myeloma patients.